JPH0339520B2 - - Google Patents

Info

Publication number
JPH0339520B2
JPH0339520B2 JP58230593A JP23059383A JPH0339520B2 JP H0339520 B2 JPH0339520 B2 JP H0339520B2 JP 58230593 A JP58230593 A JP 58230593A JP 23059383 A JP23059383 A JP 23059383A JP H0339520 B2 JPH0339520 B2 JP H0339520B2
Authority
JP
Japan
Prior art keywords
formula
calcitonin
solution
collecting
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58230593A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60123500A (ja
Inventor
Toshuki Matsuo
Kenji Sagawa
Yukio Hirose
Motoo Watabe
Tamotsu Pponma
Hidenari Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Meguro Institute Co Ltd
Original Assignee
Mitsubishi Petrochemical Co Ltd
Meguro Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Petrochemical Co Ltd, Meguro Institute Co Ltd filed Critical Mitsubishi Petrochemical Co Ltd
Priority to JP58230593A priority Critical patent/JPS60123500A/ja
Priority to EP84114768A priority patent/EP0146842B1/en
Priority to DE8484114768T priority patent/DE3462896D1/de
Publication of JPS60123500A publication Critical patent/JPS60123500A/ja
Publication of JPH0339520B2 publication Critical patent/JPH0339520B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP58230593A 1983-12-08 1983-12-08 新規カルシトニン及びその採取法 Granted JPS60123500A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58230593A JPS60123500A (ja) 1983-12-08 1983-12-08 新規カルシトニン及びその採取法
EP84114768A EP0146842B1 (en) 1983-12-08 1984-12-05 Novel calcitonin and collection thereof
DE8484114768T DE3462896D1 (en) 1983-12-08 1984-12-05 Novel calcitonin and collection thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58230593A JPS60123500A (ja) 1983-12-08 1983-12-08 新規カルシトニン及びその採取法

Publications (2)

Publication Number Publication Date
JPS60123500A JPS60123500A (ja) 1985-07-02
JPH0339520B2 true JPH0339520B2 (OSRAM) 1991-06-14

Family

ID=16910165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58230593A Granted JPS60123500A (ja) 1983-12-08 1983-12-08 新規カルシトニン及びその採取法

Country Status (3)

Country Link
EP (1) EP0146842B1 (OSRAM)
JP (1) JPS60123500A (OSRAM)
DE (1) DE3462896D1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0678357B2 (ja) * 1984-08-29 1994-10-05 三菱油化株式会社 新規ペプチド
EP0252097A1 (en) * 1985-12-19 1988-01-13 MOLONEY, Thomas J. A draw-case
FR2592049B1 (fr) * 1985-12-24 1988-02-12 Milhaud Gerard Nouveaux analogues de composes polypeptidiques hypocalcemiants epargnant le calcium de l'organisme, leur preparation et les medicaments contenant ces principes actifs
ES2097806T3 (es) * 1990-03-30 1997-04-16 Shiseido Co Ltd Procedimiento para purificar un polipeptido.
KR960031478A (ko) * 1995-02-14 1996-09-17 성재갑 유비퀴틴 융합 인간 칼시토닌의 정제방법
NL1002400C2 (nl) * 1996-02-20 1997-08-21 Friesland Brands Bv Oraal calcitonine-preparaat en werkwijze voor het winnen van calcitonine.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926938A (en) * 1974-08-12 1975-12-16 Armour Pharma Synthesis of salmon calcitonin

Also Published As

Publication number Publication date
JPS60123500A (ja) 1985-07-02
EP0146842B1 (en) 1987-04-01
DE3462896D1 (en) 1987-05-07
EP0146842A1 (en) 1985-07-03

Similar Documents

Publication Publication Date Title
Schlimme et al. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects
Eysselein et al. Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence
CLEMENT-JONES et al. Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid
Klauser et al. Characterization of isoprotein patterns in tissue extracts and isolated samples of metallothioneins by reverse-phase high-pressure liquid chromatography
JP2807660B2 (ja) 悪性−ＰＴＨｒＰの体液性高カルシウム血症において活性的なタンパク質
JP2648951B2 (ja) 人体のソマトメジン担体蛋白質サブユニットとこれらの製法
JP3178714B2 (ja) インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
HUE028539T2 (en) A peptide capable of extending the half-life of an important peptide in plasma
DK161524B (da) Fremgangsmaade til isolering af et praeparat af et osteogent protein samt et praeparat i stand til at fremme osteogenese fremstillet ved fremgangsmaaden
Conrad et al. Newly identified iron-binding protein in human duodenal mucosa
JPH06500311A (ja) ヒスチジン置換されたヒト成長ホルモン放出因子類縁体
JP2003520771A (ja) ペプチド
EP0263802B1 (en) Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide, and use of said kit of material
O'Riordan et al. Isolation and chemical properties of porcine parathyroid hormone
JPH0339520B2 (OSRAM)
SHULDINER et al. Isolation and characterization of two different insulins from an amphibian, Xenopus laevis
Watkins Immunohistochemical demonstration of neurophysin in the hypothalamoneurohypophysial system
HUT52787A (en) Process for production of biologically active peptides
Le Breton et al. Elimination kinetic of recombinant somatotropin in bovine
JPH0678357B2 (ja) 新規ペプチド
US5298605A (en) Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof
EP0041019B1 (fr) Nouveaux produits préparés à partir du facteur thymique sérique ou de ses analogues et dérivés, procédé de préparation de ces produits, ces produits pour utilisation comme médicaments, traceurs obtenus à partir de ces produits et utilisation de ces traceurs dans des procédés de dosage
Born et al. Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients
WO1989000166A2 (en) Growth hormone related peptide
Rasmussen et al. Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas